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Abstract
Background: The correlation between AAA and carotid artery plaque is unknown and a common etiology
and pathophysiology is suspected by some authors. The purpose of this work was to explore the association
between the features of a) carotid artery plaque and b) abdominal aortic aneurysm (AAA) plaques using
multi-detector-CT Angiography (MDCTA).
Methods: Forty-eight (32 males; median age 72 years) patients studied using a 16-detectors CT scanner were
retrospectively analyzed. A region of interest (ROI) ≥ 2 mm2 was used to quantify the HU value of the plaque
by two readers independently. Inter-observer reproducibility was calculated and Pearson correlation analysis was
performed.
Results: The Bland-Altman plots showed the inter-observer reproducibility to be good. The Pearson correlation was
0.224 (95 % CI = 0.071 to 0.48), without statistically significant association between HU measured in the carotid artery
plaque and in the AAA plaques (p = 0.138); after exclusion of the calcified plaques from the analysis, the rho values
resulted 0.494 (95 % CI = 0.187 to 0.713) with a statistically significant association (p = 0.003).
Conclusion: In this study, we found an association between the features of the non calcific carotid plaque and the
features of AAA plaque.
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Background
Atherosclerotic disease of carotid artery is considered
the most important cause of cerebrovascular events
[1, 2]; imaging techniques in the last years focused
their attention in finding those parameters that are
associated with an increased risk of stroke and transi-
tory ischemic attacks (TIA) [3, 4]. The concept of
"vulnerable plaque" has thus been introduced, focusing on
those atherosclerotic plaques with a high likelihood to
cause thrombotic complications [5, 6]. However, athero-
sclerosis is a process that may affect all the arterial vessels
in the body [7] and, commonly, a significant target of this
pathology is the abdominal aorta [8, 9].
The most prevalent pathology of the aorta is the
abdominal aortic aneurysm (AAA), whose rupture has
been recognized to be a significant cause of mortality for
adults aged >60 years in the developed world [10]. The
pathogenesis of AAA is still poorly understood with
some studies suggesting the importance of inflammatory
pathways, hemodynamic forces, matrix degradation and
thrombosis [11, 12]. Subjects with AAAs have frequently
atherosclerosis: Cornuz et al. [13] showed the associ-
ation of peripheral atherosclerosis with AAAs. Whether
the association between atherosclerosis and AAA is simply
due to common risk factors or is causal is unknown [14].
In the last few years MDCTA has emerged as an
outstanding technique to explore the vascular system
[15–18], and by using the Hounsfield Units (HU)
sampling it is possible to have quantitative and repro-
ducible information of the analyzed tissue [19].
The purpose of this work was to explore the associ-
ation between plaques in the carotid artery and
abdominal aortic aneurysm by using quantitative data
obtained with MDCTA.
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Forty-eight (32 males; median age 72 ± 14 years) patients
studied between August 2005 and May 2011 by using a
16-detector CT scanner (Philips Brilliance, Rotterdam,
Netherlands) were retrospectively analyzed. Patients with
medical history of cardiac output failure, or any contra-
indications to iodinated contrast media did not undergo
MDCTA exams. Criteria to be included in this study
were: 1) Patients underwent MDCTA of carotid and
abdominal aorta for AAA. 2) The time interval between
the carotid and the AAA studies was not more than
3 months. Each examination was performed when clin-
ically indicated and was ordered by the patient’s phys-
ician as part of routine clinical care. The patients were
all neurologically asymptomatic, without history of TIA
or stroke. In accordance with the applicable National
Research Ethics Service guidance, ethical approval for
the study was not required because the study was
performed retrospectively on routinely acquired images
and specimens.
MDCTA technique
All patients underwent MDCTA of the supra-aortic ves-
sels using a technique previously described [blinded for
peer review].
In our protocol for the analysis of carotid arteries, the
angiographic phase is obtained by injecting 80-110 mL of
contrast using a power injector at a flow rate of 5 mL/s. A
bolus tracking technique is used to calculate the correct
timing of the scan. Dynamic monitoring scanning begins
6 s after the beginning of the intravenous injection of con-
trast material. The trigger threshold inside the ROI is set
at + 90 HU above the baseline. The delay between the
acquisitions of each monitoring scan is 1 s. CT technical
parameters include: matrix 512x512, field of view (FOV)
14–19 cm; mAs 180–220; kV 120–140.
For the analysis of AAA, the angiographic phase is
obtained by injecting 80-110 mL of contrast medium
into a cubital vein (usually the left side was used), using
a power injector at a flow rate of 4-5 mL/s and an 18-
gauge intravenous catheter. The scan starts at the level
of the diaphragm up to the pubic symphysis. For the
study of AAA a bolus tracking technique similar to the
procedure described for the carotid arteries is used.
Image analysis
In the first phase two experienced radiologists independ-
ently measured the HU value of the carotid artery
plaques. A region of interest (ROI) ≥ 2 mm2 was used to
quantify the HU value of the plaque. After two weeks,
the same radiologists independently measured the HU
value of the AAA plaque (Fig. 1). Images were blinded
and randomized. MDCTA images were analysed with a
varying magnification from 120 to 400 % in comparison
to the acquisition.
Window parameters (width and level) were freely modi-
fiable but the parameters from another article [20] were
followed. To quantifiy the HU value, a circular or elliptical
region of interest cursor in the predominant area of
plaque was used. Regions of beam hardening in calcified
areas were excluded and areas showing contamination by
contrast material or calcification were avoided.
Statistical analysis
Continuous data were described as the mean value ±
standard deviation (SD). In order to evaluate the
inter-observer reproducibility in HU quantification,
Bland-Altman analysis with 95 % limits of agreement
(mean difference ± 1.96 SDs) was performed and the
differences between the measured values were plotted
against the mean of the 2 measurements to assess the
relationship between the difference and the magnitude
of the measurement. Mann-Whitney test was used to
test the differences between groups. For the analysis
of correlation (Pearson Rho correlation) between HU
measured in the carotid artery and AAA plaques, the
HU values between the 2 observers were averaged. R




Three patients were excluded from the final analysis
because of sub-optimal image quality due to movement
artifact. Therefore the final number of analyzed patients
was 45 (29 males; median age 72 ± 13 years). Demo-
graphic characteristics are summarized in Table 1. The
total number of carotid artery plaque measured were 79
because in 11 carotid arteries no evidence of plaque was
found. The ROI value was between 2 mm2 and 5 mm2
(mean value 2.56 mm2).
Bland-Altman analysis
We analyzed the inter-observer reproducibility of HU
measurement of the plaque in the 79 carotid arteries
and in the 45 patients with AAA and the plots are
given in the Fig. 2. The plots showed that the inter-
observer reproducibility is good for both analysis and
the best agreement is obtained in the carotid artery
plaque HU quantification (with 95 % CI from −25.5 % to
20.3 %.
Mann-Whitney analysis
We tested the differences between HU values in carotid
arteries and AAA also by using the Mann-Whitney test
and we found that there were no differences in HU ana-
lysis between the two observers in the carotids (p = 0.836)
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and in the AAA (p = 0.353). Summary statistic is given in
Table 2. These results demonstrate that the HU measure-
ment performed by the 2 observers in the carotid and
AAA plaques are not statistically different.
Pearson correlation analysis
The correlation coefficient rho was 0.224 (95 % CI = 0.071
to 0.48) and there was no statistically significant associ-
ation between HU measured in the carotid artery plaque
and HU measured in the AAA plaque (p = 0.138). The
scatter-plot with 95 % confidence interval is shown in
Fig. 3. We analyzed also the correlation between carotid
and AAA plaques by excluding the calcified plaques
(namely those plaques with HU value > 130 HU) and we
performed a further analysis by obtaining a coefficient rho
of 0.494 (95 % CI = 0.187 to 0.713) with a statistically sig-
nificant association (p = 0.003).
Discussion
In the last few years several papers demonstrated that
the plaque composition of the carotid arteries plays a
significant role in the “vulnerability” of the plaque and in
the risk of develop cerebrovascular events.
In the carotid artery (as well as in the coronary arter-
ies), it is possible to find different types of plaque [3, 4]
and the very hypodense regions (<30 HU) in the center
of atherosclerotic carotid plaque are associated with the
presence of a lipid core (i.e., lipid, hemorrhage, or nec-
rotic debris) [21, 22]; this kind of plaques are associated
with the development of cerebrovascular events [19].
Table 1 Patients characteristics
Agea 72 y (SDb 13 y)
Sex (male) 65 % (n = 31)
Hypertension 53 % (n = 25)
Smoker 62 % (n = 30)
CAD 59 % (n = 28)
Diabetes 15 % (n = 7)
Dyslipidemia 61 % (n = 29)
aMean age
bSD standard deviation
Fig. 1 MDCTA axial images of AAA (a) and carotid arteries (b, c). The AAA is indicated by the white arrow (a) and the circle represents the
analyzed ROI. The carotid artery plaques is indicated by the open white arrow (b, c) and the circle represents the analyzed ROI. Panel c represent
the 200 % zoom of the panel b
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The presence of atherosclerotic pathology and plaque
development in the AAA is well described but if this
association is simply due to common risk factors or is
causal, is still unknown [14]. In this study, our purpose
was to evaluate whether there was an association
between the HU values measured in the carotid artery
plaque and the HU values measured in the AAA plaque.
By analyzing the correlation between HU values in
carotid plaques and AAA plaques a rho value of 0.224
(95 % CI = 0.071 to 0.48) was found with the absence of
significant p-value (p = 0.138). We analyzed the morph-
ology of the scatter-plot and we found that the calcified
plaques of carotid plaques represent, for this kind of
analysis, a confounding factor. In the Fig. 3a the calcified
plaques of carotid are clearly visible (dotted circle) and
by excluding this kind of plaques the coefficient rho chan-
ged to 0.494 (95 % CI = 0.187 to 0.713) with the presence
of a statistically significant association (p = 0.003). This is
an interesting point to discuss because the presence of
carotid calcified plaques are considered a protective factor
for the development of cerebrovascular events [23, 24].
Nandalur et al. [23], demonstrated that calcified plaques
are 21 times less likely to be symptomatic than non-
calcified plaques (p = 0.030) whereas no significant pre-
dictive value was found between fatty (p = 0.23) or mixed
(p = 0.18) plaque type for the occurrence of symptoms.
The results of this study were further confirmed by Saba
et al. [19] that showed that carotid calcified plaques are
less frequently associated with cerebrovascular symptoms.
In that paper the non calcified plaques were found to be
associated with the presence of stroke-TIA.
Previous studies have attributed the development of
AAA to atherosclerosis [25] because these conditions
share risk factors, such as hypertension, smoking, and
hypercholesterolemia [26, 27]. The presence of athero-
sclerotic process in the aneurismal wall is a common find-
ing in AAA patients but several patients with advanced
atherosclerosis do not develop AAA [28, 29].
The results of this study suggest that the atherosclerotic
process involved in the carotid artery plaques and in the
wall of the AAA is of a different nature: in fact in the ca-
rotid plaques may show a calcified type (HU value > 130)
Fig. 2 Bland-Altman plot graphs for the inter-observer reproducibility in the HU measurement of the carotid artery plaque (a) and AAA plaque (b).
In panel a the dotted circle represents the carotid calcified plaques
Table 2 Mann-Whitney analysis
HU carotid artery plaque HU AAA plaque
Observer 1 Observer 2 Observer 1 Observer 2
Sample size 79 79 45 45
Lowest value 19 21 18 21
Highest value 843 812 66 63
Median 62 63 43 45
95 % CI for the median 54.88 to 67 57 to 66.12 35.27 to 46.1 40 to 49
Interquartile range 45 to 82.75 49.5 to 76.75 32 to 49 34.5 to 52
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that is not present in the AAA. Nonetheless, when the
carotid calcified plaques are excluded, a significant correl-
ation is found between the HU values in the carotid and
in the AAA.
From a pathological point of view authors reported
that AAA is characterized by transmural infiltration of
lymphocytes and macrophages and by the destruction of
elastin and collagen in the media and adventitia loss of
medial smooth muscle cells with thinning of the vessel
wall [30, 31] and these pathological elements are quite
similar in those found in the carotid (and coronary)
artery “vulnerable” plaques [3, 4, 32, 33]. A study by
Zweig et al., demonstrated that the calcifications of the
abdominal aorta correlated with the presence of calcifica-
tions in the coronary arteries and even suggested abdom-
inal aortic as a possible tool to help exclude obstructive
coronary disease and improve the selection of patients
that may benefit from further risk stratification [34].
In this type of study the analysis of reproducibility in
the HU measurement is important and Bland-Altman
plot analysis showed that the inter-observer reprodu-
cibility is good for both analysis and the best agree-
ment is obtained in the carotid artery plaque HU
quantification (with 95 % CI from −25.5 % to 20.3 %.
In the HU quantification of the carotid artery plaque
our results are concordant with previous observations
[35, 36] whereas, on the best of our knowledge no
previous analysis of concordance in the HU quantifi-
cation of AAA plaque was found. These results were
also confirmed by the Mann-Whitney test where we
found no differences in HU analysis between the two
observers in the carotids (p = 0.836) and in the AAA
(p = 0.353).
In this paper there are some limitations. First, we
quantified the HU values in the carotid and AAA by
using a circular ROI; a more precise system like manual
drawing of the plaque would be more reliable and this
fact may introduce a bias in the data analysis: however
we think that this can be considered a minor limitation
because the predominant area of the plaque was
selected. Second, the total number of analysed patients
was forty-five and this represents a relative small popula-
tion: therefore the obtained results should be further
verified in larger cohort.
Conclusion
In this study, we found an association between the fea-
tures of the non calcific carotid plaque and the features
of AAA plaque.
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